Resumo

HERNANDEZ-MERCADO, Marco A. et al. Post-COVID-19 sinus tachycardia: pathogenesis, identification and early stratification. Rev. Colomb. Cardiol. [online]. 2022, vol.29, n.4, pp.485-494.  Epub 08-Nov-2022. ISSN 0120-5633.  https://doi.org/10.24875/rccar.21000087.

COVID-19 has been responsible for a high morbi-mortality which is characterized by respiratory symptoms; its entrance to the cell is favored by angiotensin-converting enzyme 2, which is found in a variety of cells with systemic effects. The main symptoms in the cardiovascular system are: arrhythmia, heart failure, cardiogenic shock, acute coronary syndrome, bradycardia and sinus tachycardia. This disease has a prognosis that depends on genetic and demographic factors, with a progress whether to recovery, death or aftermath, then latter being described as “post-COVID-19 syndrome”. Cardiovascular compromise is reflected by the high incidence in tachycardia detected in tracing of the recovered patients of COVID-19 that refer palpitations and that during exploration of vital signs can be ascertained by an increase in heart frequency. Nevertheless its pathogenic features are still unknown, for this reason a systematic review was made with the purpose of proposing hypotheses about the physiopathological mechanisms to explain it, algorithms for early detection and a stratified treatment, so it would contribute to future investigations about the association of tachycardia as cardiovascular damage after COVID-19, due to the lack of scientific evidence in this topic.

Palavras-chave : Post-COVID; Tachycardia; COVID-19; SARS-CoV-2.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )